Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국
화요일, 9월 01

Hinge Health Inc

HNGENYSE
Trade with Public
Trade with Public
$92.56
5.215.96%
가까이에: Aug 31, 5:00 PM EST
$93.64
1.081.17%
시간외: 7:14 PM EST
개요뉴스실적 전망이벤트목표가재무심리지분 현황비교옵션주식 보고서

Hinge Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for Hinge Health (HNGE).

Price Target Range — 6 Quarters

Analyst Consensus — 18 Analysts

2S.Buy
15Buy
1Hold
Consensus RatingBuy# Analysts18Avg. Consensus PT$91Upside to Avg. PT-2.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 11, 2026Truist SecuritiesJailendra SinghPT RaiseBuy$85→$112
Aug 5, 2026RBC CapitalRishi JaluriaPT RaiseOutperform$75→$110
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Truist Securities Maintains Buy on Hinge Health, Raises Price Target to $112

Truist Securities analyst Jailendra Singh maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $85 to $112.
Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Hinge Health, Raises Price Target to $110

RBC Capital analyst Rishi Jaluria maintains Hinge Health (NYSE:HNGE) with a Outperform and raises the price target from $75 to $110.
Benzinga Newsdesk

PRO
Citizens Maintains Market Outperform on Hinge Health, Raises Price Target to $107

Citizens analyst Aaron Kimson maintains Hinge Health (NYSE:HNGE) with a Market Outperform and raises the price target from $96 to $107.
Benzinga Newsdesk

PRO
Wells Fargo Maintains Overweight on Hinge Health, Raises Price Target to $103

Wells Fargo analyst Stan Berenshteyn maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from $90 to $103.
Benzinga Newsdesk

PRO
Evercore ISI Group Maintains Outperform on Hinge Health, Raises Price Target to $105

Evercore ISI Group analyst Elizabeth Anderson maintains Hinge Health (NYSE:HNGE) with a Outperform and raises the price target from $100 to $105.
Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Hinge Health, Raises Price Target to $100

Barclays analyst Saket Kalia maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from $97 to $100.
Benzinga Newsdesk

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

시장 데이터 제공 Benzinga API

Benzinga

Benzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved